Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study)

E Florence, C Dreezen, P Desmet, E Smets, K Fransen, B Vandercam, J Pelgrom, N Clumeck, R Colebunders

Research output: Contribution to journalA1: Web of Science-articlepeer-review

Original languageEnglish
JournalAntiviral Therapy
Pages (from-to)255-262
Publication statusPublished - 2002


  • B780-tropical-medicine
  • Viral diseases
  • HIV
  • AIDS
  • Treatment
  • Clinical trial
  • Ritonavir
  • Saquinavir
  • Indinavir
  • Protease inhibitors
  • Efficacy
  • Tolerability
  • Safety

Cite this